Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness.

Sullivan SG, Tchetgen Tchetgen EJ, Cowling BJ.

Am J Epidemiol. 2016 Sep 1;184(5):345-53. doi: 10.1093/aje/kww064.

PMID:
27587721
2.

Estimating the Effect of School Water, Sanitation, and Hygiene Improvements on Pupil Health Outcomes.

Garn JV, Brumback BA, Drews-Botsch CD, Lash TL, Kramer MR, Freeman MC.

Epidemiology. 2016 Sep;27(5):752-60. doi: 10.1097/EDE.0000000000000522.

3.

Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.

Wang Y, Berlin JA, Pinheiro J, Wilcox MA.

Clin Trials. 2015 Jun;12(3):265-75. doi: 10.1177/1740774515572352. Epub 2015 Mar 1.

4.

Estimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal cancer study.

Zeng D, Chen Q, Chen MH, Ibrahim JG; AMGEN RESEARCH GROUP.

Biometrika. 2012 Mar;99(1):167-184. Epub 2011 Dec 29.

5.

Nonadherence to treatment protocol in published randomised controlled trials: a review.

Dodd S, White IR, Williamson P.

Trials. 2012 Jun 18;13:84. doi: 10.1186/1745-6215-13-84. Review.

6.

Gene-environment interaction testing in family-based association studies with phenotypically ascertained samples: a causal inference approach.

Fardo DW, Liu J, Demeo DL, Silverman EK, Vansteelandt S.

Biostatistics. 2012 Jul;13(3):468-81. doi: 10.1093/biostatistics/kxr035. Epub 2011 Nov 13.

7.

Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial.

Cole SR, Stuart EA.

Am J Epidemiol. 2010 Jul 1;172(1):107-15. doi: 10.1093/aje/kwq084. Epub 2010 Jun 14.

8.

Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization.

Toh S, Hernández-Díaz S, Logan R, Robins JM, Hernán MA.

Epidemiology. 2010 Jul;21(4):528-39. doi: 10.1097/EDE.0b013e3181df1b69.

9.
10.

Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or death.

Cole SR, Jacobson LP, Tien PC, Kingsley L, Chmiel JS, Anastos K.

Am J Epidemiol. 2010 Jan 1;171(1):113-22. doi: 10.1093/aje/kwp329. Epub 2009 Nov 24.

11.

Effect of highly active antiretroviral therapy on incident AIDS using calendar period as an instrumental variable.

Cain LE, Cole SR, Greenland S, Brown TT, Chmiel JS, Kingsley L, Detels R.

Am J Epidemiol. 2009 May 1;169(9):1124-32. doi: 10.1093/aje/kwp002. Epub 2009 Mar 24.

Supplemental Content

Support Center